We discovered that FGL2 secreted from tumor cells is the primary suppressor of differentiation of antigen-presenting CD103+ DCs via blocking of granulocyte-macrophage colony-stimulating factor (GM-CSF) signal transduction and subsequent T cell functions in the brain. The gene discussed is CSF2; the disease is neoplasm.